Skin iron deposition characterises lipodermatosclerosis and leg ulcer.
BACKGROUND
It is commonly reported that chronic venous disease (CVD) increases the skin iron content in which the excess is stored as haemosiderin. Despite increasing interest in the role of haemosiderin in venous ulceration, no study has systematically evaluated the occurrence of iron overload in the limbs of patients with CVD.


OBJECTIVE
To evaluate skin haemosiderin deposition in relation to the presence and severity of skin changes in CVD legs designated according to the clinical, etiologic, anatomic and pathophysiologic (CEAP) classification.


METHODS
A total of 85 skin biopsies were taken from the medial aspect of 49 limbs with CVD of CEAP clinical stages C2, C3, C4 and C6. The content of ferric ions was assessed by Perl's Prussian Blue (PPB) stain.


RESULTS
No haemosiderin deposition was found in normal skin of C2, C3 and C4A legs, in less severe regions of pigmentation and in some parts of more severely affected limbs. Haemosiderin was always present in lipodermatosclerotic skin and ulcers. Occasionally, haemosiderin was found in the apparently normal perilesional skin of C4b and C6 legs. The regenerating dermis at the base of healing ulcers showed none or light haemosiderin deposition.


CONCLUSIONS
Iron overload is not present in the less severe stages of skin damage due to CVD but lipodermatosclerosis and leg ulcers are always accompanied by haemosiderin deposition. In fact, no severe skin changes occur in CVD legs until iron overload occurs. Our results are in agreement with previous reports suggesting that a genetic inability to counteract skin iron overload is present in these patients. A more detailed analysis of disordered iron metabolism should be undertaken in CVD patients.
Caggiati
A
A
Department of Anatomy, Sapienza University of Rome, Italy. alberto.caggiati@uniroma1.it
Rosi
C
C
Casini
A
A
Cirenza
M
M
Petrozza
V
V
Acconcia
M C
MC
Zamboni
P
P
D001706:Biopsy; D003872:Dermatitis / Q000378:metabolism / Q000473:pathology; D005260:Female; D006485:Hemosiderin / Q000032:analysis; D006801:Humans; D017495:Hyperpigmentation / Q000378:metabolism / Q000473:pathology; D007501:Iron / Q000032:analysis*; D019190:Iron Overload / Q000378:metabolism* / Q000473:pathology; D007558:Italy; D007871:Leg Ulcer / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012594:Scleroderma, Localized / Q000378:metabolism / Q000473:pathology; D012720:Severity of Illness Index; D012867:Skin / Q000737:chemistry* / Q000473:pathology; D012880:Skin Pigmentation; D014945:Wound Healing
D006485:Hemosiderin; D007501:Iron